{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:27:20Z","timestamp":1790008040675,"version":"4.0.1"},"reference-count":46,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Michigan State University College of Veterinary Medicine Endowed Research Funds","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>While the genetic contributions to the predisposition of Bernese mountain dogs (BMDs) to histiocytic sarcoma (HS) remains unclear, some insights into key genetic drivers have been gained. Our group recently reported a mutation in the PTPN11 gene (E76K). We have now identified a second missense mutation in PTPN11 (G503V), and a mutation in KRAS (Q61H) present in HS cell lines. These mutations are associated with malignancies in humans, and known to be gain-of-function mutations that result in activation of the mitogen-activated protein kinase (MAPK) pathway. The goal of the present study was to evaluate the prevalence of these mutations in a large sample of HS cases from BMDs and golden retrievers, and in lymphoma cases, from a cohort of BMDs. Mutations in PTPN11 were present in HS in 41\/96 (43%) BMDs, and in 3\/13 (23%) golden retrievers. PTPN11 mutations E76K and G503V did not coexist in the same neoplasm. The KRAS mutation was much less frequent, with a prevalence of 3.1% (3\/96). We did not identify either PTPN11 nor KRAS mutations in any of the lymphoma samples. These results point out the potential relevance of PTPN11 and KRAS mutations as activators of the oncogenic MAPK pathway for canine HS, particularly in BMDs.<\/jats:p>","DOI":"10.3390\/genes10070505","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T11:13:18Z","timestamp":1562238798000},"page":"505","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Activating Mutations in PTPN11 and KRAS in Canine Histiocytic Sarcomas"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9509-0528","authenticated-orcid":false,"given":"Marilia","family":"Takada","sequence":"first","affiliation":[{"name":"Comparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Smyth","sequence":"additional","affiliation":[{"name":"Comparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuddow","family":"Thaiwong","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, Lansing, MI 48910, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlee","family":"Richter","sequence":"additional","affiliation":[{"name":"Comparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Corner","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, Lansing, MI 48910, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Z.","family":"Schall","sequence":"additional","affiliation":[{"name":"Comparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4429-9529","authenticated-orcid":false,"given":"Matti","family":"Kiupel","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, Lansing, MI 48910, USA"},{"name":"Pathobiology &amp; Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-1279","authenticated-orcid":false,"given":"Vilma","family":"Yuzbasiyan-Gurkan","sequence":"additional","affiliation":[{"name":"Comparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cvsm.2005.09.011","article-title":"Updates in therapeutics for veterinary dermatology","volume":"36","author":"Bruner","year":"2006","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/jhered\/esp039","article-title":"Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed","volume":"100","author":"Abadie","year":"2009","journal-title":"J. Hered."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/vco.12252","article-title":"Clinical prognostic factors in canine histiocytic sarcoma","volume":"15","author":"Dervisis","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"ref_4","first-page":"115","article-title":"Mortality in a cohort of flat-coated retrievers in the UK","volume":"7","author":"Dobson","year":"2009","journal-title":"Vet. Comp. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1476-5810.2006.00090.x","article-title":"Histiocytic sarcomas in flat-coated retrievers: A summary of 37 cases (November 1998-March 2005)","volume":"4","author":"Fidel","year":"2006","journal-title":"Vet. Comp. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1354\/vp.39-1-74","article-title":"Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs","volume":"39","author":"Affolter","year":"2002","journal-title":"Vet. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1354\/vp.39-1-66","article-title":"The diagnosis and prognosis of synovial tumors in dogs: 35 cases","volume":"39","author":"Craig","year":"2002","journal-title":"Vet. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1939-1676.2007.tb02937.x","article-title":"CCNU for the treatment of dogs with histiocytic sarcoma","volume":"21","author":"Skorupski","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/jvim.13964","article-title":"Risk Factors Associated with Development of Histiocytic Sarcoma in Bernese Mountain Dogs","volume":"30","author":"Ruple","year":"2016","journal-title":"J. Vet. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2460\/javma.239.1.90","article-title":"Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma","volume":"239","author":"Klahn","year":"2011","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/jsap.12354","article-title":"Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma","volume":"56","author":"Cannon","year":"2015","journal-title":"J. Small Anim. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1476-5829.2010.00211.x","article-title":"Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs","volume":"8","author":"Rassnick","year":"2010","journal-title":"Vet. Comp. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hedan, B., Thomas, R., Motsinger-Reif, A., Abadie, J., Andre, C., Cullen, J., and Breen, M. (2011). Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-201"},{"key":"ref_14","first-page":"1019","article-title":"The MTAP-CDKN2A locus confers susceptibility to a naturally occurring canine cancer","volume":"21","author":"Shearin","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","article-title":"Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis","volume":"103","author":"Loh","year":"2004","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","article-title":"Activating mutations of the noonan syndrome-associated SHP2\/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia","volume":"64","author":"Paez","year":"2004","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10038-005-0239-7","article-title":"Functional analysis of PTPN11\/SHP-2 mutants identified in Noonan syndrome and childhood leukemia","volume":"50","author":"Niihori","year":"2005","journal-title":"J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1074\/jbc.M507622200","article-title":"Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling","volume":"281","author":"Yu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/0008-5472.CAN-17-1510","article-title":"Therapeutic Targeting of Oncogenic Tyrosine Phosphatases","volume":"77","author":"Frankson","year":"2017","journal-title":"Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.3324\/haematol.2017.179150","article-title":"Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma","volume":"103","author":"Voruz","year":"2018","journal-title":"Haematologica"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00428-016-1965-2","article-title":"Somatic mutations in histiocytic sarcoma identified by next generation sequencing","volume":"469","author":"Liu","year":"2016","journal-title":"Virchows Arch."},{"key":"ref_24","first-page":"3179147","article-title":"Histiocytic Sarcoma Associated with Coombs Negative Acute Hemolytic Anemia: A Rare Presentation","volume":"2016","author":"Batra","year":"2016","journal-title":"Case Rep. Oncol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/nan.12404","article-title":"An aggressive multifocal primary CNS histiocytosis with PTPN11 (Shp2) mutation","volume":"44","author":"Zhang","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_26","unstructured":"Jaffe, E.S., and World Health Organization (2001). Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press."},{"key":"ref_27","first-page":"376","article-title":"Histiocytoses of lymph nodes: biology and differential diagnosis","volume":"5","author":"Jaffe","year":"1988","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/modpathol.3800346","article-title":"Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163","volume":"18","author":"Vos","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2017-10-812495","article-title":"Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes","volume":"131","author":"Kommalapati","year":"2018","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/vco.12357","article-title":"Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs","volume":"16","author":"Thaiwong","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1158\/1535-7163.MCT-17-1273","article-title":"Targeting MEK in a Translational Model of Histiocytic Sarcoma","volume":"17","author":"Takada","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02623551","article-title":"A macrophage-monocyte cell line from a dog with malignant histiocytosis","volume":"24","author":"Wellman","year":"1988","journal-title":"Vitr. Cell. Dev. Biol. J. Tissue Cult. Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vetimm.2014.11.006","article-title":"Passage-dependent morphological and phenotypical changes of a canine histiocytic sarcoma cell line (DH82 cells)","volume":"163","author":"Heinrich","year":"2015","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Takada, M., Parys, M., Gregory-Bryson, E., Vilar Saavedra, P., Kiupel, M., and Yuzbasiyan-Gurkan, V. (2018). A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4132-0"},{"key":"ref_36","unstructured":"Lowry, R. (2018, April 20). VassarStats: Website for Statistical Computation. Available online: http:\/\/vassarstats.net\/index.html."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","article-title":"The \u2018Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling","volume":"28","author":"Neel","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood.V97.4.911","article-title":"Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development","volume":"97","author":"Qu","year":"2001","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0300985810385153","article-title":"The clinical presentation and histopathologic-immunohistochemical classification of histiocytic sarcomas in the Flat Coated Retriever","volume":"48","author":"Mayhew","year":"2011","journal-title":"Vet. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"941275","DOI":"10.1155\/2013\/941275","article-title":"Breed-predispositions to cancer in pedigree dogs","volume":"2013","author":"Dobson","year":"2013","journal-title":"ISRN Vet. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/vr.147.11.291","article-title":"Histopathological survey of neoplasms in flat-coated retrievers, 1990 to 1998","volume":"147","author":"Morris","year":"2000","journal-title":"Vet. Rec."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Shanmugam, V., Griffin, G.K., Jacobsen, E.D., Fletcher, C.D.M., Sholl, L.M., and Hornick, J.L. (2019). Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod. Pathol.","DOI":"10.1038\/s41379-018-0200-x"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms","volume":"567","author":"Diamond","year":"2019","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Takada, M., Smyth, L.A., Hix, J.M., Corner, S.M., O\u2019Reilly, S., Kiupel, M., and Yuzbasiyan-Gurkan, V. (2019). Development of an Orthotopic Intrasplenic Xenograft Mouse Model of Canine Histiocytic Sarcoma and Its Use in Evaluating the Efficacy of Treatment with Dasatinib. Comp. Med.","DOI":"10.30802\/AALAS-CM-18-000065"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/7\/505\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:02:31Z","timestamp":1760187751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/7\/505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7]]}},"alternative-id":["genes10070505"],"URL":"https:\/\/doi.org\/10.3390\/genes10070505","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]}}}